Analyses performed in the BAL fluids showed that the chemokines CCL3 and CCL5 and the proinflammatory molecules IL-1β and IL-6 were significantly higher in patient 1 compared to the non-COVID-19 bLTx patient (Supplementary Figure S6A and Table S2). This evidence concerns the gene CCL5 and COVID-19.